Fresenius Medical Care AG & Co. KGaA
Rating
Updated: Sep 4, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Th...
Latest News
4 days ago · defenseworld.net
Tidal Investments LLC Buys 48,885 Shares of Fresenius Medical Care AG & Co. KGaA $FMSTidal Investments LLC grew its stake in shares of Fresenius Medical Care AG and Co. KGaA (NYSE: FMS) by 96.0% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 99,790 shares of the company's stock after acquiring an additional
18 days ago · zacks.com
Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?Fresenius Medical is scaling its 5008X rollout across U.S. clinics, creating growth potential despite volume, reimbursement and rollout-cost pressures.
18 days ago · zacks.com
Reasons to Retain Fresenius Medical Stock in Your Portfolio for NowFresenius Medical's improving profitability, 5008X rollout and value-based care gains offer support despite volume and reimbursement risks.
1 month ago · defenseworld.net
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Share Price Passes Above 200 Day Moving Average – Time to Sell?Fresenius Medical Care AG and Co. KGaA (NYSE: FMS - Get Free Report) shares passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $23.13 and traded as high as $23.92. Fresenius Medical Care AG and Co. KGaA shares last traded at $23.43,
1 month ago · youtube.com
3 Cheap International Stocks to BuyThese stocks have economic moats and look attractive today.
2 months ago · defenseworld.net
Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call HighlightsFresenius Medical Care AG and Co. KGaA (NYSE: FMS) reported second-quarter 2026 organic revenue growth of 5% and a 23% increase in operating income at constant currency, while confirming its full-year outlook despite weaker U.S. treatment volumes and anticipated reimbursement-related headwinds in the second half. Chief Executive Officer Helen Giza said the company's operating-income growth accelerated
2 months ago · zacks.com
FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins ExpandFMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.
2 months ago · businesswire.com
Silicon Motion Showcases Next-Generation Storage Solutions for Agentic AI Applications at FMS 2026TAIPEI, Taiwan--(BUSINESS WIRE)-- #AIStorage--Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion”), a global leader in designing and marketing NAND flash controllers for solid-state storage devices, today announced it will showcase its latest storage innovations for AI Factory, Edge AI, and Physical AI applications at Future of Memory and Storage (FMS) 2026, taking place August 4 to 6 in Santa Clara, California, at Booth #315. As AI evolves beyond large language model training toward Ag.
2 months ago · seekingalpha.com
Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call TranscriptFresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript
2 months ago · wsj.com
Fresenius Medical Care Shares Drop After U.S. Treatment Volumes Fall FurtherShares fell, wiping out most of their gains since the start of the year, after the German dialysis specialist reported another decline in U.S. treatment volumes in the second quarter.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove FMS